{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:44:04Z","timestamp":1786160644109,"version":"build-2736575974"},"reference-count":49,"publisher":"Japan Endocrine Society","issue":"8","funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["BE2023745"],"award-info":[{"award-number":["BE2023745"]}],"id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["H2023137"],"award-info":[{"award-number":["H2023137"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0648","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:09:11Z","timestamp":1776463751000},"page":"923-937","source":"Crossref","is-referenced-by-count":0,"title":["ZFP36-ferroptosis axis as a key renal protective pathway in diabetic kidney disease"],"prefix":"10.1507","volume":"73","author":[{"given":"Anni","family":"Li","sequence":"first","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Ye","sequence":"first","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Cao","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Hu","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shi","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liu","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6273-4419","authenticated-orcid":false,"given":"Bixia","family":"Gu","sequence":"additional","affiliation":[{"name":"Women\u2019s Hospital of Nanjing Medical University, Nanjing Women and Children\u2019s Healthcare Hospital, Nanjing 210004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1382-9831","authenticated-orcid":false,"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Affiliated Huai\u2019an No. 1 People\u2019s Hospital of Nanjing Medical University, Huai\u2019an 223300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Duncan BB, Thom\u00e9 FS, Vos T (2024) The global burden of disease study\u2014a kidney disease resource. Nephrol Dial Transplant 39: 1751\u20131753.","DOI":"10.1093\/ndt\/gfae136"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Thomas B (2019) The global burden of diabetic kidney disease: time trends and gender gaps. Curr Diab Rep 19: 18.","DOI":"10.1007\/s11892-019-1133-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kanwar YS, Sun L, Xie P, Liu FY, Chen S (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6: 395\u2013423.","DOI":"10.1146\/annurev.pathol.4.110807.092150"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Harreiter J, Roden M (2023) Diabetes mellitus: definition, classification, diagnosis, screening and prevention (Update 2023). Wien Klin Wochenschr 135: 7\u201317 (in German).","DOI":"10.1007\/s00508-022-02122-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, et al. (2008) The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 4: 382\u2013393.","DOI":"10.1038\/ncpendmet0843"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, et al. (2022) IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183: 109119.","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 (2020) KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 98: S1\u2013S115.","DOI":"10.1016\/j.kint.2020.06.019"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Zeng Z, Wang X, Chen Y, Zhou H, Zhu W, et al. (2023) Health-related quality of life in Chinese individuals with type 2 diabetes mellitus: a multicenter cross-sectional study. Health Qual Life Outcomes 21: 100.","DOI":"10.1186\/s12955-023-02183-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Wang Y, Lin T, Lu J, He W, Chen H, et al. (2025) Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study. Diabetes Obes Metab 27: 1902\u20131919.","DOI":"10.1111\/dom.16183"},{"key":"10","unstructured":"10 (2022) Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition). Zhonghua Nei Ke Za Zhi 61: 12\u201350 (in Chinese)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Liu Z, Liu J, Wang W, An X, Luo L, et al. (2023) Epigenetic modification in diabetic kidney disease. Front Endocrinol (Lausanne) 14: 1133970.","DOI":"10.3389\/fendo.2023.1133970"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Cole JB, Florez JC (2020) Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol 16: 377\u2013390.","DOI":"10.1038\/s41581-020-0278-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kato M, Natarajan R (2019) Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat Rev Nephrol 15: 327\u2013345.","DOI":"10.1038\/s41581-019-0135-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Akhtar M, Taha NM, Nauman A, Mujeeb IB, Al-Nabet A (2020) Diabetic kidney disease: past and present. Adv Anat Pathol 27: 87\u201397.","DOI":"10.1097\/PAP.0000000000000257"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol 12: 2032\u20132045.","DOI":"10.2215\/CJN.11491116"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Guedes M, Pecoits-Filho R (2022) Can we cure diabetic kidney disease? Present and future perspectives from a nephrologist\u2019s point of view. J Intern Med 291: 165\u2013180.","DOI":"10.1111\/joim.13424"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22: 266\u2013282.","DOI":"10.1038\/s41580-020-00324-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Sun S, Shen J, Jiang J, Wang F, Min J (2023) Targeting ferroptosis opens new avenues for the development of novel therapeutics. Signal Transduct Target Ther 8: 372.","DOI":"10.1038\/s41392-023-01606-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, et al. (2022) Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci 24: 499.","DOI":"10.3390\/ijms24010449"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Liu J, Kang R, Tang D (2022) Signaling pathways and defense mechanisms of ferroptosis. FEBS J 289: 7038\u20137050.","DOI":"10.1111\/febs.16059"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Qiu B, Zandkarimi F, Bezjian CT, Reznik E, Soni RK, et al. (2024) Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187: 1177\u20131190.e18.","DOI":"10.1016\/j.cell.2024.01.030"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Wang H, Yu X, Liu D, Qiao Y, Huo J, et al. (2024) VDR activation attenuates renal tubular epithelial cell ferroptosis by regulating Nrf2\/HO-1 signaling pathway in diabetic nephropathy. Adv Sci (Weinh) 11: e2305563.","DOI":"10.1002\/advs.202305563"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, et al. (2020) Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol 27: 420\u2013435.","DOI":"10.1016\/j.chembiol.2020.02.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Sha W, Hu F, Xi Y, Chu Y, Bu S (2021) Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res 2021: 9999612.","DOI":"10.1155\/2021\/9999612"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Wang L, Liu Y, Du T, Yang H, Lei L, et al. (2020) ATF3 promotes erastin-induced ferroptosis by suppressing system Xc<sup>\u2013<\/sup>. Cell Death Differ 27: 662\u2013675.","DOI":"10.1038\/s41418-019-0380-z"},{"key":"26","first-page":"1","volume":"13","author":"F Deng","year":"2021","unstructured":"26 Deng F, Zhao BC, Yang X, Lin ZB, Sun QS, et al. (2021) The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes 13: 1\u201321.","journal-title":"Gut Microbes","ISSN":"https:\/\/id.crossref.org\/issn\/1949-0976","issn-type":"print"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bi Y, Liu S, Qin X, Abudureyimu M, Wang L, et al. (2024) FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner. J Adv Res 55: 45\u201360.","DOI":"10.1016\/j.jare.2023.02.012"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Li P, Jiang M, Li K, Li H, Zhou Y, et al. (2021) Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol 22: 1107\u20131117.","DOI":"10.1038\/s41590-021-00993-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W (2023) GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer 1878: 188890.","DOI":"10.1016\/j.bbcan.2023.188890"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, et al. (2022) Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int 102: 248\u2013260.","DOI":"10.1016\/j.kint.2022.05.012"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Zhong S, Wang N, Zhang C (2024) Podocyte death in diabetic kidney disease: potential molecular mechanisms and therapeutic targets. Int J Mol Sci 25: 9035.","DOI":"10.3390\/ijms25169035"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wang H, Liu D, Zheng B, Yang Y, Qiao Y, et al. (2023) Emerging role of ferroptosis in diabetic kidney disease: molecular mechanisms and therapeutic opportunities. Int J Biol Sci 19: 2678\u20132694.","DOI":"10.7150\/ijbs.81892"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33 Park HS, Song JW, Park JH, Lim BK, Moon OS, et al. (2021) TXNIP\/VDUP1 attenuates steatohepatitis <i>via<\/i> autophagy and fatty acid oxidation. Autophagy 17: 2549\u20132564.","DOI":"10.1080\/15548627.2020.1834711"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Zhang T, Liu Q, Gao W, Sehgal SA, Wu H (2022) The multifaceted regulation of mitophagy by endogenous metabolites. Autophagy 18: 1216\u20131239.","DOI":"10.1080\/15548627.2021.1975914"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Xu R, Song J, Ruze R, Chen Y, Yin X, et al. (2023) SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src\/PI3K\/Akt signaling pathway. Cell Death Dis 14: 497.","DOI":"10.1038\/s41419-023-05987-7"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Williams MJ, Alsehli AM, Gartner SN, Clemensson LE, Liao S, et al. (2022) The statin target Hmgcr regulates energy metabolism and food intake through central mechanisms. Cells 11: 970.","DOI":"10.3390\/cells11060970"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Li W, Han J, Huang B, Xu T, Wan Y, et al. (2025) SLC25A1 and ACLY maintain cytosolic acetyl-CoA and regulate ferroptosis susceptibility <i>via<\/i> FSP1 acetylation. Embo J 44: 1641\u20131662.","DOI":"10.1038\/s44318-025-00369-5"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Gao Q, Chen JM, Li CS, Zhan JY, Yin XD, et al. (2024) CDKN1A promotes Cis-induced AKI by inducing cytoplasmic ROS production and ferroptosis. Food Chem Toxicol 193: 115003.","DOI":"10.1016\/j.fct.2024.115003"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Cao Y, Sun Q, Chen Z, Lu J, Geng T, et al. (2022) CDKN2AIP is critical for spermiogenesis and germ cell development. Cell Biosci 12: 136.","DOI":"10.1186\/s13578-022-00861-z"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Zhang L, Long J, Jiang W, Shi Y, He X, et al. (2016) Trends in chronic kidney disease in China. N Engl J Med 375: 905\u2013906.","DOI":"10.1056\/NEJMc1602469"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Hu Q, Jiang L, Yan Q, Zeng J, Ma X, et al. (2023) A natural products solution to diabetic nephropathy therapy. Pharmacol Ther 241: 108314.","DOI":"10.1016\/j.pharmthera.2022.108314"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Rayego-Mateos S, Rodrigues-Diez RR, Fernandez-Fernandez B, Mora-Fern\u00e1ndez C, Marchant V, et al. (2023) Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int 103: 282\u2013296.","DOI":"10.1016\/j.kint.2022.10.030"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Qi J, Kim JW, Zhou Z, Lim CW, Kim B (2020) Ferroptosis affects the progression of nonalcoholic steatohepatitis <i>via<\/i> the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol 190: 68\u201381.","DOI":"10.1016\/j.ajpath.2019.09.011"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Guo H, Jiang Y, Gu Z, Ren L, Zhu C, et al. (2022) ZFP36 protects against oxygen-glucose deprivation\/reoxygenation-induced mitochondrial fragmentation and neuronal apoptosis through inhibiting NOX4-DRP1 pathway. Brain Res Bull 179: 57\u201367.","DOI":"10.1016\/j.brainresbull.2021.12.003"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Cook ME, Bradstreet TR, Webber AM, Kim J, Santeford A, et al. (2022) The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses. Sci Immunol 7: eabo0981.","DOI":"10.1126\/sciimmunol.abo0981"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Yadav S, El Hamra R, Alturki NA, Ariana A, Bhan A, et al. (2024) Regulation of Zfp36 by ISGF3 and MK2 restricts the expression of inflammatory cytokines during necroptosis stimulation. Cell Death Dis 15: 574.","DOI":"10.1038\/s41419-024-06964-4"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Zhang X, Zhao S, Yuan Q, Zhu L, Li F, et al. (2021) TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis 12: 642.","DOI":"10.1038\/s41419-021-03930-2"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Han Y, Xu X, Tang C, Gao P, Chen X, et al. (2018) Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol 16: 32\u201346.","DOI":"10.1016\/j.redox.2018.02.013"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Ling C (2020) Epigenetic regulation of insulin action and secretion\u2013role in the pathogenesis of type 2 diabetes. J Intern Med 288: 158\u2013167.","DOI":"10.1111\/joim.13049"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/8\/73_EJ25-0648\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:28:55Z","timestamp":1786159735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/8\/73_EJ25-0648\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0648","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0648"}}